4//SEC Filing
Wolfe Peter 4
Accession 0001641172-25-019729
CIK 0001859007other
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 4:22 PM ET
Size
5.6 KB
Accession
0001641172-25-019729
Insider Transaction Report
Form 4
Wolfe Peter
Chief Financial Officer
Transactions
- Award
Stock Options
2025-07-11+60,100→ 60,100 totalExercise: $0.59Exp: 2035-07-11→ Common Stock (60,100 underlying)
Footnotes (1)
- [F1]The options were granted on July 11, 2025, and vest and become exercisable in equal annual installments on the first three anniversaries of the grant date, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
ZyVersa Therapeutics, Inc.
CIK 0001859007
Entity typeother
Related Parties
1- filerCIK 0001954398
Filing Metadata
- Form type
- 4
- Filed
- Jul 14, 8:00 PM ET
- Accepted
- Jul 15, 4:22 PM ET
- Size
- 5.6 KB